Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Current Leases (2020 - 2025)

Mereo BioPharma (MREO) has disclosed Current Leases for 6 consecutive years, with $202000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases fell 71.43% to $202000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $202000.0 through Dec 2025, down 71.43% year-over-year, with the annual reading at $202000.0 for FY2025, 71.43% down from the prior year.
  • Current Leases for Q4 2025 was $202000.0 at Mereo BioPharma, down from $397000.0 in the prior quarter.
  • The five-year high for Current Leases was $838462.6 in Q4 2021, with the low at $202000.0 in Q4 2025.
  • Average Current Leases over 5 years is $616860.2, with a median of $662000.0 recorded in 2024.
  • The sharpest move saw Current Leases increased 15.6% in 2023, then crashed 71.43% in 2025.
  • Over 5 years, Current Leases stood at $838462.6 in 2021, then plummeted by 32.73% to $564000.0 in 2022, then rose by 15.6% to $652000.0 in 2023, then grew by 8.44% to $707000.0 in 2024, then plummeted by 71.43% to $202000.0 in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $202000.0, $397000.0, and $601000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.